Pfizer Marks Phase III Success in Hemophilia A, then Layoffs after Failure in DMD.

Alex Philippidis

Published in: Human gene therapy (2024)

Keyphrases

phase iii
duchenne muscular dystrophy
open label
clinical trial
double blind
phase ii
muscular dystrophy
placebo controlled
study protocol